packageGanirelix

ganirelix

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ganirelix is a hormone antagonist used to prevent premature ovulation in women undergoing assisted reproduction and fertility treatment, such as controlled ovarian stimulation. It is an approved medicine, authorised in the European Union, and is used in specialist fertility care rather than broadly in routine practice.

Summary written by glm-5.3-flash from Wikidata Q5521314 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ganirelix
ATC codes:H01CC01
DrugBank:DB06785
PubChem CID:16130957
ChEBI:135910
Wikidata:Q5521314
formula:C80H113ClN18O13
molar mass:1570.35 g/mol (PubChem CID 16130957)
logP:5.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown